Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma

References

• Ansari SA, Pendurthi UR, Rao LVM. (2017). The lipid peroxidation product 4-hydroxy-2-nonenal induces tissue factor decryption via ROS generation and the thioredoxin system. Blood Adv 1:2399–413.
   PubMed Web of Science ®Google Scholar
• Avanesov A, Honeyager SM, Malicki J, Blair SS. (2012). The role of glypicans in Wnt inhibitory factor-1 activity and the structural basis of Wif1's effects on Wnt and Hedgehog signaling. PLoS Genet 8:e1002503.
   PubMed Web of Science ®Google Scholar
• Brasacchio D, Alsop AE, Noori T, et al. (2017). Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization. Cell Death Differ 24:961–70.
   PubMed Web of Science ®Google Scholar
• Chiang DY, Villanueva A. (2017). Progress towards molecular patient stratification of hepatocellular carcinoma: lost in translation? J Hepatol 67:893–5.
   PubMed Web of Science ®Google Scholar
• Dargel C, Bassani-Sternberg M, Hasreiter J, et al. (2015). T cells engineered to express a T-cell receptor specific for glypican-3 to recognize and kill hepatoma cells in vitro and in mice. Gastroenterology 149:1042–52.
   PubMed Web of Science ®Google Scholar
• Forget A, Burzava AL, Delalat B, et al. (2017). Rapid fabrication of functionalised poly(dimethylsiloxane) microwells for cell aggregate formation. Biomater Sci 5:828–36.
   PubMed Web of Science ®Google Scholar
• Gao W, Tang Z, Zhang YF, et al. (2015). Immunotoxin targeting glypican-3 regresses liver cancer via dual inhibition of Wnt signalling and protein synthesis. Nat Commun 6:6536.
   PubMed Web of Science ®Google Scholar
• Guha A, Biswas N, Bhattacharjee K, et al. (2016). pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation. Drug Deliv 23:3552–61.
   PubMed Web of Science ®Google Scholar
• Hsieh CH, Wang JP, Chiu CC, et al. (2018). A triazole-conjugated benzoxazone induces reactive oxygen species and promotes autophagic apoptosis in human lung cancer cells. Apoptosis 23:1–15.
   PubMed Web of Science ®Google Scholar
• Inoue-Yamauchi A, Jeng PS, Kim K, et al. (2017). Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy. Nat Commun 8:16078.
   PubMed Web of Science ®Google Scholar
• Kim M-S, Saunders AM, Hamaoka BY, et al. (2011). Structure of the protein core of the glypican Dally-like and localization of a region important for hedgehog signaling. Proc Natl Acad Sci USA 108:13112–7.
   PubMed Web of Science ®Google Scholar
• Li H, Li Y, Wang X, et al. (2017). Rational design of polymeric hybrid micelles to overcome lymphatic and intracellular delivery barriers in cancer immunotherapy. Theranostics 7:4383–98.
   PubMed Web of Science ®Google Scholar
• Lin T, Gao D, Liu Y, et al. (2016). Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis. J Control Release 221:62–70.
   PubMed Web of Science ®Google Scholar
• Lin Q, Yang Y, Hu Q, et al. (2017). Injectable supramolecular hydrogel formed from α-cyclodextrin and PEGylated arginine-functionalized poly(l-lysine) dendron for sustained MMP-9 shRNA plasmid delivery. Acta Biomater 49:456–71.
   PubMed Web of Science ®Google Scholar
• Liu G, Gao H, Zuo Y, et al. (2017). DACHPt-loaded unimolecular micelles based on hydrophilic dendritic block copolymers for enhanced therapy of lung cancer. ACS Appl Mater Interfaces 9:112–9.
   PubMed Web of Science ®Google Scholar
• Liu B, Jiang T, Zheng H, et al. (2017). Nanoengineering of aggregation-free and thermally-stable gold nanoparticles in mesoporous frameworks. Nanoscale 9:6380–90.
   PubMed Web of Science ®Google Scholar
• Li M, Wang W, Dan Y, et al. (2016). Downregulation of amplified in breast cancer 1 contributes to the anti-tumor effects of sorafenib on human hepatocellular carcinoma. Oncotarget 7:29605–19.
   PubMedGoogle Scholar
• Lian H, He Z, Meng Z. (2017). Rational design of hybrid nanomicelles integrating mucosal penetration and P-glycoprotein inhibition for efficient oral delivery of paclitaxel. Colloids Surf B Biointerfaces 155:429–39.
   PubMed Web of Science ®Google Scholar
• Martínez-Torres AC, Reyes-Ruiz A, Benítez-Londoño M, et al. (2018). IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production. BMC Cancer 18:13.
   PubMed Web of Science ®Google Scholar
• Mei L, Zhang Y, Zheng Y, et al. (2009). A novel docetaxel-loaded poly(ε-caprolactone)/pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment. Nanoscale Res Lett 4:1530–9.
   PubMed Web of Science ®Google Scholar
• Nakamura I, Iimuro Y, Hai S, et al. (2018). Impaired value of 99m Tc-GSA scintigraphy as an independent risk factor for posthepatectomy liver failure in patients with hepatocellular carcinoma. Eur Surg Res 9:12–22.
   Web of Science ®Google Scholar
• Parikh A, Kathawala K, Tan CC, et al. (2017). Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation. Drug Deliv 24:962–78.
   PubMed Web of Science ®Google Scholar
• Parikh ND, Marshall VD, Singal AG, et al. (2017). Survival and cost-effectiveness of sorafenib therapy in advanced hepatocellular carcinoma: an analysis of the SEER-Medicare database. Hepatology 65:122–33.
   PubMed Web of Science ®Google Scholar
• Pinter M, Weinmann A, Wörns MA, et al. (2017). Use of inhibitors of the renin-angiotensin system is associated with longer survival in patients with hepatocellular carcinoma. United Eur Gastroenterol J 5:987–96.
   PubMed Web of Science ®Google Scholar
• Presti G, Guarrasi V, Gulotta E, et al. (2017). Bioactive compounds from extra virgin olive oils: correlation between phenolic content and oxidative stress cell protection. Biophys Chem 230:109–16.
   PubMed Web of Science ®Google Scholar
• Rashidi M, Bandala-Sanchez E, Lawlor KE, et al. (2018). CD52 inhibits Toll-like receptor activation of NF-κB and triggers apoptosis to suppress inflammation. Cell Death Differ 25:392–405.
   PubMed Web of Science ®Google Scholar
• Sharma S, Verma A, Pandey G, et al. (2015). Investigating the role of pluronic-g-cationic polyelectrolyte as functional stabilizer for nanocrystals: impact on paclitaxel oral bioavailability and tumor growth. Acta Biomater 26:169–83.
   PubMed Web of Science ®Google Scholar
• Sivalingam KS, Paramasivan P, Weng CF, Viswanadha VP. (2017). Neferine potentiates the antitumor effect of cisplatin in human lung adenocarcinoma cells via a mitochondria-mediated apoptosis pathway. J Cell Biochem 118:2865–76.
   PubMed Web of Science ®Google Scholar
• Tang J, Ji H, Ren J, et al. (2017). Solid lipid nanoparticles with TPGS and Brij 78: a co-delivery vehicle of curcumin and piperine for reversing P-glycoprotein-mediated multidrug resistance in vitro. Oncol Lett 13:389–95.
   PubMed Web of Science ®Google Scholar
• Tang X, Zhu H, Sun L, et al. (2014). Enhanced antifungal effects of amphotericin B-TPGS-b-(PCL-ran-PGA) nanoparticles in vitro and in vivo. Int J Nanomedicine 9:5403–13.
   PubMed Web of Science ®Google Scholar
• Totaro A, Salerno A, Imparato G, et al. (2017). PCL-HA microscaffolds for in vitro modular bone tissue engineering. J Tissue Eng Regen Med 11:1865–75.
   PubMed Web of Science ®Google Scholar
• Won JK, Yu SJ, Hwang CY, et al. (2017). Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma. Hepatology 66:855–68.
   PubMed Web of Science ®Google Scholar
• Zaker A, Asili J, Abrishamchi P, et al. (2017). Cytotoxic and apoptotic effects of root extract and tanshinones isolated from Perovskia abrotanoides Kar. Iran J Basic Med Sci 20:1377–84.
   PubMed Web of Science ®Google Scholar
• Zhou W, Yu H, Zhang LJ, et al. (2017). Redox-triggered activation of nanocarriers for mitochondria-targeting cancer chemotherapy. Nanoscale 9:17044–53.
   PubMed Web of Science ®Google Scholar
• Zhu ZW, Friess H, Wang L, et al. (2001). Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 48:558–64.
   PubMed Web of Science ®Google Scholar
• Zhu YJ, Zheng B, Wang HY, Chen L. (2017). New knowledge of the mechanisms of sorafenib resistance in liver cancer. Acta Pharmacol Sin 38:614–22.
   PubMed Web of Science ®Google Scholar